KIMS Subsidiary Receives Favorable Income Tax Order, Demand Set Aside
KIMS subsidiary SPANV Medisearch received a favorable order from the Income Tax Department on March 29, 2026. The demand notice for assessment year 2022-2023 has been set aside, resulting in zero payable amount. No financial impact is anticipated.
The announcement states that there is no quantifiable impact on the company's financial, operational, or other activities, indicating a low impact.
The Income Tax Department has set aside a demand notice against the company's subsidiary, resulting in zero payable amount, which is a positive outcome.
Krishna Institute of Medical Sciences Limited (KIMS) announced that its subsidiary, SPANV Medisearch Lifesciences Private Limited, has received a favorable order from the Income Tax Department. This order, dated March 29, 2026, pertains to the assessment year 2022-2023.
Previously, SPANV had received a demand notice under Section 156 of the IT Act, against which an appeal was filed. The Income Tax Department, through an order under Section 143(3) read with sections 250 and 144B of the Income-tax Act, has now set aside the said demand notice.
Consequently, the amount payable in this matter is ₹0 (Zero). The company has also confirmed that this development has no quantifiable impact on its financial, operational, or other activities. The subsidiary received this information on March 31, 2026, at 3:43 PM.
What to do with a filing like this
Krishna Institute of Medical Sciences Limited filed this with the NSE as a statutory disclosure, categorised under other regulatory filings. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Krishna Institute of Medical Sciences Limited. Read the original for the full detail.